• Users Online: 117
  • Print this page
  • Email this page


 
 
Table of Contents
LETTER TO THE EDITOR
Year : 2020  |  Volume : 8  |  Issue : 4  |  Page : 218

A case report of pulmonary mucormycosis


Department of Paediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq

Date of Submission18-Jul-2020
Date of Decision30-Sep-2020
Date of Acceptance07-Oct-2020
Date of Web Publication23-Oct-2020

Correspondence Address:
Prof. Mahmood Dhahir Al-Mendalawi
Department of Paediatrics, Al-Kindy College of Medicine, University of Baghdad, P.O. Box 55302, Baghdad Post Office, Baghdad
Iraq
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ajim.ajim_52_20

Rights and Permissions

How to cite this article:
Al-Mendalawi MD. A case report of pulmonary mucormycosis. APIK J Int Med 2020;8:218

How to cite this URL:
Al-Mendalawi MD. A case report of pulmonary mucormycosis. APIK J Int Med [serial online] 2020 [cited 2020 Nov 30];8:218. Available from: https://www.ajim.in/text.asp?2020/8/4/218/298936



Sir,

In July–September 2020 issue of the APIK Journal of Internal Medicine , Taur et al. [1] published a case of pulmonary mucormycosis (PM) in an Indian patient. As mucormycosis is a rare opportunistic mycotic infection, often occurs in individuals with low immunity, and imposes significant morbidity and mortality,[2] I wonder why Taur et al. [1] did not consider immunocompromised status in the studied patient, particularly infection with human immunodeficiency virus (HIV). Truly, PM has been reported in HIV-infected patients.[3],[4] India is currently challenging HIV epidemic. The available data pointed to the national adult prevalence of 0.22% (0.16%–0.30%) in 2017.[5] The employed diagnostic panel in the studied patient did not regrettably recruit HIV testing. I assume that the diagnostic set of fourth-generation assay for P24 antigen and antibodies, as well as measuring viral overload and CD4 lymphocyte count, would have to be taken into consideration. If that set was to address HIV seropositivity, the case in question could be really regarded as a novel case report of HIV-associated PM in the Indian literature.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Taur SR, Harsoor S, Goudagaon C. A case report of pulmonary mucormycosis. APIK J Int Med 2020;8:136-8.  Back to cited text no. 1
  [Full text]  
2.
Moreira J, Varon A, Galhardo MC, Santos F, Lyra M, Castro R, et al . The burden of mucormycosis in HIV-infected patients: A systematic review. J Infect 2016;73:181-8.  Back to cited text no. 2
    
3.
Harloff KJ, Stoehr A, Wasmuth R, Plettenberg A, Harten J. Pulmonary mucormycosis in an HIV-infected patient. Dtsch Med Wochenschr 1995;120:94-8.  Back to cited text no. 3
    
4.
Kutlu M, Ergin C, Bir F, Hilmioǧlu-Polat S, Gümral R, Necan C, et al . Pulmonary mucormycosis due to Lichtheimia ramosa in a patient with HIV infection. Mycopathologia 2014;178:111-5.  Back to cited text no. 4
    
5.
Government of India, Ministry of Health & Family Welfare, National AIDS Control Organisation. HIV Facts & Figures. Available from: http://naco.gov.in/hiv-facts-figures. [Last accessed on 2020 Jul 17].  Back to cited text no. 5
    




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed63    
    Printed0    
    Emailed0    
    PDF Downloaded11    
    Comments [Add]    

Recommend this journal